Somatosensory dysfunction is masked by variable cognitive deficits across patients on the Alzheimer's disease spectrum
- PMID: 34689085
- PMCID: PMC8550984
- DOI: 10.1016/j.ebiom.2021.103638
Somatosensory dysfunction is masked by variable cognitive deficits across patients on the Alzheimer's disease spectrum
Abstract
Background: Alzheimer's disease (AD) is generally thought to spare primary sensory function; however, such interpretations have drawn from a literature that has rarely taken into account the variable cognitive declines seen in patients with AD. As these cognitive domains are now known to modulate cortical somatosensory processing, it remains possible that abnormalities in somatosensory function in patients with AD have been suppressed by neuropsychological variability in previous research.
Methods: In this study, we combine magnetoencephalographic (MEG) brain imaging during a paired-pulse somatosensory gating task with an extensive battery of neuropsychological tests to investigate the influence of cognitive variability on estimated differences in somatosensory function between biomarker-confirmed patients on the AD spectrum and cognitively-normal older adults.
Findings: We show that patients on the AD spectrum exhibit largely non-significant differences in somatosensory function when cognitive variability is not considered (p-value range: .020-.842). However, once attention and processing speed abilities are considered, robust differences in gamma-frequency somatosensory response amplitude (p < .001) and gating (p = .004) emerge, accompanied by significant statistical suppression effects.
Interpretation: These findings suggest that patients with AD exhibit insults to functional somatosensory processing in primary sensory cortices, but these effects are masked by variability in cognitive decline across individuals.
Funding: National Institutes of Health, USA; Fremont Area Alzheimer's Fund, USA.
Keywords: Amyloid-β; Gamma oscillations; Magnetoencephalography; Neuropsychology; Sensory gating.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest All authors declare no conflicts of interest. Dr. Murman reported receiving grants from Green Valley Pharmaceuticals, Functional Neuromodulation, Roche, and Eli Lilly and Co. and serving on an advisory board for Biogen. Dr. Wilson reported serving as a board member for the American Clinical Magnetoencephalography Society and the International Society for the Advancement of Clinical Magnetoencephalography.
Figures





Similar articles
-
Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease.Brain. 2018 May 1;141(5):1470-1485. doi: 10.1093/brain/awy044. Brain. 2018. PMID: 29522156 Free PMC article.
-
Regional functional connectivity predicts distinct cognitive impairments in Alzheimer's disease spectrum.Neuroimage Clin. 2014 Jul 23;5:385-95. doi: 10.1016/j.nicl.2014.07.006. eCollection 2014. Neuroimage Clin. 2014. PMID: 25180158 Free PMC article.
-
Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.J Alzheimers Dis. 2021;79(2):819-832. doi: 10.3233/JAD-200890. J Alzheimers Dis. 2021. PMID: 33361593 Free PMC article.
-
Visuospatial alpha and gamma oscillations scale with the severity of cognitive dysfunction in patients on the Alzheimer's disease spectrum.Alzheimers Res Ther. 2021 Aug 17;13(1):139. doi: 10.1186/s13195-021-00881-w. Alzheimers Res Ther. 2021. PMID: 34404472 Free PMC article.
-
Alzheimer's Disease: Past, Present, and Future.J Int Neuropsychol Soc. 2017 Oct;23(9-10):818-831. doi: 10.1017/S135561771700100X. J Int Neuropsychol Soc. 2017. PMID: 29198280 Free PMC article. Review.
Cited by
-
Hemispheric Cortical, Cerebellar and Caudate Atrophy Associated to Cognitive Impairment in Metropolitan Mexico City Young Adults Exposed to Fine Particulate Matter Air Pollution.Toxics. 2022 Mar 25;10(4):156. doi: 10.3390/toxics10040156. Toxics. 2022. PMID: 35448417 Free PMC article.
-
Cannabis- and HIV-related perturbations to the cortical gamma dynamics supporting inhibitory processing.Brain Commun. 2025 May 15;7(3):fcaf190. doi: 10.1093/braincomms/fcaf190. eCollection 2025. Brain Commun. 2025. PMID: 40421314 Free PMC article.
-
Structural and neurophysiological alterations in Parkinson's disease are aligned with cortical neurochemical systems.medRxiv [Preprint]. 2023 Apr 5:2023.04.04.23288137. doi: 10.1101/2023.04.04.23288137. medRxiv. 2023. Update in: Ann Neurol. 2024 Apr;95(4):802-816. doi: 10.1002/ana.26871. PMID: 37066346 Free PMC article. Updated. Preprint.
-
Signatures of somatosensory cortical dysfunction in Alzheimer's disease and HIV-associated neurocognitive disorder.Brain Commun. 2022 Jun 23;4(4):fcac169. doi: 10.1093/braincomms/fcac169. eCollection 2022. Brain Commun. 2022. PMID: 35813878 Free PMC article.
-
Sensory processing deficits and related cortical pathological changes in Alzheimer's disease.Front Aging Neurosci. 2023 Aug 15;15:1213379. doi: 10.3389/fnagi.2023.1213379. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37649717 Free PMC article. Review.
References
-
- Uylings H.B., De Brabander J. Neuronal changes in normal human aging and Alzheimer's disease. Brain Cogn. 2002;49(3):268–276. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials